16 results
8-K
EX-10.1
TFFP
Tff Pharmaceuticals Inc
2 May 24
TFF Pharmaceuticals Announces Pricing of $4.8 Million Public Offering
5:10pm
of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, “Hazardous Materials”) into the environment, or otherwise
8-K
EX-10.1
TFFP
Tff Pharmaceuticals Inc
22 Mar 24
TFF Pharmaceuticals Announces $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
4:25pm
strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous
8-K
EX-1.1
q1jz 8kr41o
18 Nov 22
TFF Pharmaceuticals Prices $10.675 Million Offering of Common Stock and Warrants
5:15pm
8-K
EX-1.1
tis9kr6 ixdytbs
10 Jun 22
Entry into a Material Definitive Agreement
4:35pm
8-K
EX-1.1
g8s34ncnvcnycde5r6x
26 Mar 21
TFF Pharmaceuticals Prices Offering of Common Stock
8:37am
8-K
EX-10.1
2c098s8 re
11 Aug 20
TFF Pharmaceuticals Announces $25.9 Million in Financing to Further Advance its Thin Film Freezing Technology Platform
9:05am
S-1/A
EX-1.1
79eweth 5hi
28 Sep 19
IPO registration (amended)
1:59am
S-1
EX-10.12
aj13931zrg2b
20 Aug 19
IPO registration
4:55pm
S-1
EX-10.10
urclpp
20 Aug 19
IPO registration
4:55pm
S-1
EX-10.2
h1gxezezk u1dkedvvit
20 Aug 19
IPO registration
4:55pm
DRS/A
EX-10.12
6cst0ad
17 Jul 19
Draft registration statement (amended)
12:00am
DRS/A
EX-10.10
btxxm
17 Jul 19
Draft registration statement (amended)
12:00am
DRS
EX-10.1
28v6c7ez3 xo0
11 Oct 18
Draft registration statement
12:00am
- Prev
- 1
- Next